{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:10Z","timestamp":1786986850062,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clinre.2023.102223","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:08:12Z","timestamp":1696392492000},"page":"102223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["New epidemiologic trends in cholangiocarcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Alina","family":"Pascale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rosmorduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Duclos-Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinre.2023.102223_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0002","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.clinre.2020.03.024","article-title":"Epidemiology of cholangiocarcinoma; United States incidence and mortality trends","volume":"44","author":"Gad","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102223_bib0003","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0004","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2023.102223_bib0005","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s10620-014-3276-2","article-title":"Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification","volume":"59","author":"Tyson","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.clinre.2023.102223_bib0006","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1477-2574.2012.00536.x","article-title":"Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival","volume":"14","author":"Witjes","year":"2012","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0007","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/annonc\/mds652","article-title":"A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe","volume":"24","author":"Bertuccio","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinre.2023.102223_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2023.102223_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.clinre.2023.102223_bib0010","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","article-title":"Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017","volume":"27","author":"Javle","year":"2022","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.clinre.2023.102223_bib0011","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.21146","article-title":"Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand","volume":"117","author":"Honjo","year":"2005","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.clinre.2023.102223_bib0012","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1572-0241.2008.01796.x","article-title":"Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study","volume":"103","author":"Lee","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102223_bib0013","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3748\/wjg.14.632","article-title":"Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China","volume":"14","author":"Zhou","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0014","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1499-3872(11)60106-9","article-title":"Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study","volume":"10","author":"Liu","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"10.1016\/j.clinre.2023.102223_bib0015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jamcollsurg.2007.12.045","article-title":"Choledochal cyst disease in children and adults: a 30-year single-institution experience","volume":"206","author":"Edil","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000268109","article-title":"Management of congenital bile duct cysts","volume":"27","author":"Mabrut","year":"2010","journal-title":"Dig Surg"},{"issue":"3","key":"10.1016\/j.clinre.2023.102223_bib0017","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.22283","article-title":"Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study","volume":"120","author":"Welzel","year":"2007","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0018","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0019","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0021","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1038\/s41598-021-90175-w","article-title":"Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Aune","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2023.102223_bib0023","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2023.102223_bib0024","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD","volume":"111","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102223_bib0025","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2023.102223_bib0026","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2023.102223_bib0027","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.clinre.2023.102223_bib0028","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0029","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.22606","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans","volume":"49","author":"El-Serag","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.clinre.2023.102223_bib0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6605063","article-title":"Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma","volume":"100","author":"Lee","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2023.102223_bib0032","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","article-title":"Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies","volume":"13","author":"Li","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clinre.2023.102223_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3417976","article-title":"HBV infection status and the risk of cholangiocarcinoma in Asia: a meta-analysis","volume":"2016","author":"Zhang","year":"2016","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.clinre.2023.102223_bib0034","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2023.102223_bib0035","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T","article-title":"Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis","volume":"88","author":"Kobayashi","year":"2000","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.clinre.2023.102223_bib0036","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1002\/cncr.24471","article-title":"Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases","volume":"115","author":"Wu","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2023.102223_bib0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-12-289","article-title":"Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.clinre.2023.102223_bib0038","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.30559","article-title":"Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study","volume":"123","author":"Mahale","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.clinre.2023.102223_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186643","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based study in SEER-Medicare","volume":"12","author":"Petrick","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis","volume":"17","author":"Wongjarupong","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0041","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MEG.0000000000001684","article-title":"Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis","volume":"33","author":"Corrao","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clinre.2023.102223_bib0042","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4251\/wjgo.v13.i9.1121","article-title":"Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis","volume":"13","author":"Hoskins","year":"2021","journal-title":"World J Gastrointest Oncol"},{"issue":"18","key":"10.1016\/j.clinre.2023.102223_bib0043","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/jnci\/djs351","article-title":"Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome","volume":"104","author":"Win","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clinre.2023.102223_bib0044","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:34:20Z","timestamp":1761896060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740123001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2210740123001481"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102223","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New epidemiologic trends in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102223"}}